Z Factor Ltd, a Cambridge-based drug development company spun out of the University of Cambridge, announced that the first human volunteer was dosed today with ZF874, its novel treatment for alpha-1-antitrypsin deficiency (AATD). AATD is a common genetic disorder, affecting around in 1 in 2000 people in Western countries, whereContinue Reading

RICHLAND, WA- The Wishing Star Foundation is a non-profit based out of Spokane that grants the wishes of children ages 3-21 with terminal, life threatening or medically complicated conditions. Friday the non-profit granted the wish of a young Richland girl named Oaklee McBride. Oaklee has Alpha-1 Antitrypsin Deficiency an inherited condition thatContinue Reading